Vaccine-induced immune thrombotic thrombocytopenia


BLOOD SPOTLIGHT| APRIL 6, 2023 Douglas B. Cines, Andreas Greinacher Blood (2023) 141 (14): 1659–1665. https://doi.org/10.1182/blood.2022017696 Within the first months of the COVID-19 vaccination campaign, previously healthy recipients who developed severe thrombosis (often cerebral and/or splanchnic vasculature) and thrombocytopenia typically after adenoviral vector-based vaccination were identified. Similarities between this syndrome, vaccine-induced immune thrombotic thrombocytopenia (VITT), and heparin-induced […]

Predictive Role of Biomarkers in COVID-19 Mortality


Ayşe Yılmaz,1 Öztürk Taşkın,1 Ufuk Demir,1 and Veysel G Soylu2 Cureus. 2023 Jan; 15(1): e34173. Published online 2023 Jan 24 doi: 10.7759/cureus.34173 PMCID: PMC9950690PMID: 36843833 Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in high mortality among patients in critical intensive care units. Hence, identifying mortality markers in the follow-up and treatment of these patients is essential. This study aimed to evaluate […]

Role of neutrophil-epithelial interactions in SARS-CoV-2 infection


Authors: By Suchandrima BhowmikAug 15 2021Reviewed by Benedette Cuffari, M.Sc. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus that causes coronavirus disease 2019 (COVID-19), is associated with high mortality and hospitalization rates. However, many patients who are infected with SARS-CoV-2 remain asymptomatic or develop mild symptoms. In a recent study published on the […]